Acasti Pharma Inc (ACST)
2.87
+0.02
(+0.70%)
USD |
NASDAQ |
Apr 23, 16:00
2.60
-0.27
(-9.41%)
After-Hours: 20:00
Acasti Pharma Cash from Investing (TTM): -1.452M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -1.452M |
September 30, 2023 | 0.101M |
June 30, 2023 | -0.105M |
March 31, 2023 | 13.15M |
December 31, 2022 | 8.172M |
September 30, 2022 | 13.73M |
June 30, 2022 | 16.66M |
March 31, 2022 | -3.522M |
December 31, 2021 | -11.95M |
September 30, 2021 | -13.88M |
June 30, 2021 | -16.75M |
March 31, 2021 | -9.858M |
December 31, 2020 | -1.84M |
September 30, 2020 | -0.815M |
June 30, 2020 | 2.584M |
March 31, 2020 | 8.138M |
December 31, 2019 | 11.78M |
September 30, 2019 | -0.1989M |
June 30, 2019 | -3.719M |
March 31, 2019 | -9.442M |
December 31, 2018 | -12.78M |
September 30, 2018 | -0.5508M |
June 30, 2018 | -0.4613M |
March 31, 2018 | -0.3183M |
December 31, 2017 | 0.2088M |
Date | Value |
---|---|
September 30, 2017 | 2.142M |
June 30, 2017 | 2.602M |
November 30, 2016 | 2.575M |
August 31, 2016 | 4.914M |
May 31, 2016 | 5.758M |
February 29, 2016 | 6.073M |
November 30, 2015 | 7.346M |
August 31, 2015 | 8.054M |
May 31, 2015 | 6.814M |
February 28, 2015 | 6.096M |
November 30, 2014 | -15.16M |
August 31, 2014 | -16.81M |
May 31, 2014 | -18.04M |
February 28, 2014 | -17.48M |
November 30, 2013 | 2.708M |
August 31, 2013 | 1.116M |
May 31, 2013 | 2.169M |
February 28, 2013 | 1.855M |
November 30, 2012 | 2.357M |
August 31, 2012 | -2.535M |
May 31, 2012 | -3.278M |
February 29, 2012 | -3.009M |
November 30, 2011 | -5.208M |
August 31, 2011 | -1.535M |
May 31, 2011 | -2.062M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-16.75M
Minimum
Jun 2021
16.66M
Maximum
Jun 2022
0.5389M
Average
-0.1989M
Median
Sep 2019
Cash from Investing (TTM) Benchmarks
Aurinia Pharmaceuticals Inc | -6.706M |
Edesa Biotech Inc | 0.00 |
Lexaria Bioscience Corp | -0.1991M |
Xenon Pharmaceuticals Inc | -117.17M |
ESSA Pharma Inc | 6.200M |